Spruce Biosciences, Inc.
NASDAQ:SPRBBiotechnology
Healthcare
$40.49 +5.07%
+$2.47 today
- Market cap
- $116.37M
- Beta
- 3.20
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$27.11
52W Low $7.00High $838.13
Volume 0.05M
Average 0.06M
Balance Sheet
Inspect the capital base behind the business.
Assets
$53.02M
FY 2025 · Annual
+17.3% YoYLiabilities
$10.51M
FY 2025 · Annual
-35.9% YoYEquity
$42.52M
FY 2025 · Annual
+47.5% YoYBalance Sheet
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 42.75M | 24.49M | 96.34M | 38.75M | 48.91M |
| Short-term Investments | 46.22M | 54.59M | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 396K | 1.21M | 1.97M | 2.28M | 2.85M |
| Total Current Assets | 91.9M | 83.61M | 102.18M | 44.21M | 52.11M |
| Property, Plant & Equipment (Net) | 1.48M | 1.4M | 1.18M | 934K | 666K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 32.46M | (54.54M) | 0 | 0 | 36K |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 653K | 55.18M | 582K | 69K | 207K |
| Total Non-current Assets | 34.59M | 2.04M | 1.76M | 1M | 909K |
| Total Assets | 126.49M | 85.65M | 103.95M | 45.21M | 53.02M |
| Account Payables | 2.82M | 1.43M | 3.33M | 1.3M | 943K |
| Short-term Debt | 0 | 1.62M | 1.62M | 1.62M | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 4.91M | 0 | 0 |
| Other Current Liabilities | 1.44M | 1.29M | 11.25M | 882K | 1.77M |
| Total Current Liabilities | 8.87M | 12.45M | 24.47M | 15.25M | 10.09M |
| Long-term Debt | 4.88M | 3.29M | 1.72M | 124K | 419K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 73K | 161K | 236K | 282K | 0 |
| Total Non-current Liabilities | 6.24M | 4.72M | 2.97M | 1.14M | 419K |
| Total Liabilities | 15.12M | 17.16M | 27.44M | 16.39M | 10.51M |
| Common Stock | 3K | 3K | 4K | 4K | 0 |
| Retained Earnings | (103.13M) | (149.31M) | (197.23M) | (250.27M) | (289.23M) |
| Accumulated OCI | (184K) | (558K) | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 111.37M | 68.49M | 76.51M | 28.82M | 42.52M |
| Total Debt | 6.53M | 6.32M | 4.61M | 2.77M | 736K |
| Net Debt | (36.22M) | (18.17M) | (91.73M) | (35.99M) | (48.17M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $54.1M |
| Other Current | $952.0K |
| Total Current Assets | $55.0M |
| PP&E (Net) | $595.0K |
| Long-term Investments | $36.0K |
| Other Non-current | $503.0K |
| Total Non-current Assets | $1.1M |
| Total Assets | $56.2M |
Analysis
Selected assets total $56.2M for Latest. The largest visible component is Cash & Equivalents at $54.1M, about 96.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 9, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| SC 13G | SC 13G filing | Aug 14, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 14, 2026 | |
| SC 13G | SC 13G filing | Aug 14, 2026 |
How much cash does SPRB have?
Spruce Biosciences, Inc. (SPRB) reported $48.91M in cash and equivalents in fiscal 2025.
How much debt does SPRB carry?
Spruce Biosciences, Inc. (SPRB) reported $736,000.00 of total debt, with net debt of -$48.17M.
Continue the stock analysis
Jump to another research area for this company.